VT-WT1 (ViGenCell)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVT-WT1 (ViGenCell)
Drug Alias NameWT1- specific cytotoxic T lymphocytesVT-WT1-LVT-WT1VT-WT1-A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVigencell IncCatholic University Of Korea
China Registration ClassN/A

Develop Information

Active CompaniesCatholic University Of KoreaVigencell Inc
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A